METHOD FOR PREDICTING THE CLINICAL EFFECT AFTER A KIDNEY REVASCULARIZATION SURGERY IN PATIENTS WITH ISCHEMIC NEPHROPATHY Russian patent published in 2018 - IPC A61B5/20 G09B23/28 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to cardiovascular surgery, and can be used when predicting the clinical effect of kidney revascularization in patients with renal artery stenosis and ischemic nephropathy. To do this, the urine is tested for microalbuminuria. Daily urine is collected from patient, volume is measured to accuracy of 5 ml, 50 ml of spontaneous urine are taken in a separate container. Then, urine is tested for microalbuminuria by immunoturbidimetry. At microalbuminuria level less than 30 mg/day or less than 20 mg/l of a spontaneous urine sample, operative treatment in the volume of angioplasty and stenting of renal arteries is justified with a high probability of recovery of renal function after surgery. At microalbuminuria level of more than 30 mg/day or more than 20 mg/l of a spontaneous urine sample, the probability of restoration of renal function is low and surgical treatment is ineffective.

EFFECT: method provides the most accurate prediction of the clinical effect of kidney revascularization in this category of patients due to the specificity of the method allowing to assess the degree of damage to the glomerular apparatus of the kidneys.

1 cl, 2 ex